# Boswellia in Oncology Overview

**Boswellia** refers to resin from species such as *Boswellia serrata*, *B. sacra*, and *B. carterii*. Many readers know it by the more familiar name **frankincense**. In oncology research, the main compounds of interest are the **boswellic acids**, especially **AKBA** (*3-O-Acetyl-11-keto-β-boswellic acid*), which is the most studied anticancer constituent.

### Special report

{% hint style="info" %}

#### Featured deep dive

[**Hydroxychloroquine + Boswellia**](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/hydroxychloroquine-+-boswellia.md) **(+Urolithin A for protection)** This short report explains why this is one of the more compelling strategies built around AKBA.

It covers upstream plus downstream autophagy blockade, the prostate-cancer xenograft signal, why **HCQ** is more clinically relevant than **chloroquine**, and the main mitochondrial and cardiac cautions and finally a possible workaround in Urolithin A .

[**Read more**](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/hydroxychloroquine-+-boswellia.md)
{% endhint %}

### At a Glance

* **What it is:** A resin-derived triterpene extract from Boswellia, often known traditionally as frankincense
* **Main active focus in oncology:** AKBA
* **Why it matters:** It targets inflammation, survival signalling, angiogenesis, metastasis, treatment resistance, and brain-tumour-related oedema
* **Best-supported use today:** Adjunctive use, especially around inflammatory burden, radiotherapy support, and neuro-oncology relevance
* **Main limitation:** Oral bioavailability varies and formulation standardisation matters greatly.

### Traditional use

Boswellia resin has been used for thousands of years in Ayurvedic, Middle Eastern, and North African traditions. It has long been used for inflammatory conditions, pain, wound support, and systemic illness.

### Active constituents

Key boswellic acids include:

* **AKBA** — 3-O-Acetyl-11-keto-β-boswellic acid
* **KBA** — 11-keto-β-boswellic acid
* **ABA** — 3-O-Acetyl-β-boswellic acid
* **α-BA and β-BA**

In oncology, **AKBA** is the main compound of interest and should be treated as the most relevant standardisation marker.

### Why Boswellia is studied in oncology

Boswellia attracted oncology interest because of its unusually strong anti-inflammatory activity. Research then expanded when investigators found that AKBA also influences apoptosis, NF-κB, PI3K/Akt, EGFR-related signalling, metastasis, angiogenesis, and treatment resistance.

It is especially notable in **neuro-oncology**, where Boswellia has clinical relevance for reducing radiation-induced cerebral oedema while also showing tumour-directed biological activity.

### Clinical Positioning

Current evidence best supports Boswellia as an investigational adjunct rather than a standalone anticancer therapy.

Its strongest current practical roles are in the overlap between:

* inflammation reduction
* radiotherapy support
* cerebral oedema management in brain tumour settings
* multi-pathway adjunctive support
* resistance-modifying strategies in selected preclinical models

### Evidence Quality Rating

**3.5/5 — Moderate-to-strong preclinical evidence with emerging clinical data**

This rating reflects substantial mechanistic work, meaningful early human data, and unusually relevant clinical findings in glioblastoma-related oedema and early breast-cancer tissue response.

### Boswellia deep dive, where to go next

* [Evidence Summary](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/evidence-summary.md)
* [Anticancer Mechanisms](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/anticancer-mechanisms.md)
* [Evidence by Cancer Type](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type.md)
* [Redox Dual Action](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/redox-dual-action.md)
* [NRF2 Impact](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/nrf2-impact.md)
* [Ferroptosis Findings](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/ferroptosis-findings.md)
* [Immune Effects](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/immune-effects.md)
* [Pharmacokinetics & Metabolism](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/pharmacokinetics-and-metabolism.md)
* [Dosing & Timing](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/dosing-and-timing.md)
* [Safety & Interactions](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/safety-and-interactions.md)
* [Synergistic Combinations](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/synergistic-combinations.md)
* [Hydroxychloroquine + Boswellia](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/hydroxychloroquine-+-boswellia.md)
* [Sourcing Quality Boswellia](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/sourcing-quality-boswellia.md)

### Key References

Anti-cancer properties of boswellic acids: mechanism of action as an anti-cancerous agent\
<https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1187181/full>

The anti-proliferative effects of a frankincense extract in a window of opportunity Phase Ia clinical trial for patients with breast cancer\
<https://pmc.ncbi.nlm.nih.gov/articles/PMC10959833/>

An Update on Pharmacological Potential of Boswellic Acids in Cancer\
<https://pmc.ncbi.nlm.nih.gov/articles/PMC6747466/>

### Jump to another Boswellia page

**Core pages**

* [Boswellia in Oncology Overview](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-in-oncology-overview.md)
* [Evidence Summary](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/evidence-summary.md)
* [Anticancer Mechanisms](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/anticancer-mechanisms.md)
* [Boswellia Evidence by Cancer Type](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type.md)

**Mechanism deep dives**

* [Redox Dual Action](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/redox-dual-action.md)
* [NRF2 Impact](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/nrf2-impact.md)
* [Ferroptosis Findings](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/ferroptosis-findings.md)
* [Immune Effects](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/immune-effects.md)

**Practical pages**

* [Pharmacokinetics & Metabolism](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/pharmacokinetics-and-metabolism.md)
* [Safety & Interactions](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/safety-and-interactions.md)
* [Synergistic Combinations](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/synergistic-combinations.md)
* [Hydroxychloroquine + Boswellia](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/hydroxychloroquine-+-boswellia.md)
* [Dosing & Timing](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/dosing-and-timing.md)
* [Sourcing Quality Boswellia](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/sourcing-quality-boswellia.md)

**Cancer-type pages**

* [Glioblastoma & Brain Tumours](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type/glioblastoma-and-brain-tumours.md)
* [Breast Cancer](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type/breast-cancer.md)
* [Colorectal Cancer](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type/colorectal-cancer.md)
* [Pancreatic Cancer](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type/pancreatic-cancer.md)
* [Prostate Cancer](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type/prostate-cancer.md)
* [Non-Small Cell Lung Cancer](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type/non-small-cell-lung-cancer.md)
* [Ovarian Cancer](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type/ovarian-cancer.md)
* [Other Cancer Types](/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type/other-cancer-types.md)

{% hint style="warning" %}
This information is for education only. It is not medical advice, diagnosis, or treatment. Please speak with a qualified clinician before making changes to care, medication, or supplement use.
{% endhint %}

{% hint style="info" %}
© 2026 Abbey Mitchell. All rights reserved. Please share by URL rather than copying page text.
{% endhint %}


---

# Agent Instructions: Querying This Documentation

If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question.

Perform an HTTP GET request on the current page URL with the `ask` query parameter:

```
GET https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-in-oncology-overview.md?ask=<question>
```

The question should be specific, self-contained, and written in natural language.
The response will contain a direct answer to the question and relevant excerpts and sources from the documentation.

Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.
